ARTICLE | Company News
BioTime, Jade Therapeutics deal
July 23, 2012 7:00 AM UTC
BioTime granted Jade an exclusive sublicense to use HyStem hydrogels for facilitating time-release topical delivery of recombinant human growth hormone to treat lesions on the ocular surface. HyStem h...